Notícias e Atividades da Rome Therapeutics
Presença
Sede: Estados Unidos
Fusão, aquisição e financiamento envolvendo Rome Therapeutics.
- Pretzel Therapeutics has announced the acquisition of Rome Therapeutics (publicado em 19 de janeiro de 2026).
Executivos
Veja o organograma con seus 14 executivos principais
Biografias mais buscadas da Rome Therapeutics
- Rosana Kapeller, President, Chief Executive Officer and Director
- Jeb Keiper, Director
- Jeff Hatfield, Chairman of the Board
Recentes movimentos de executivos em Rome Therapeutics
- Sarah Knutson, Senior Director, Early Discovery, deixou a Companhia (Notícia publicada em 19 de janeiro de 2026).
Criar um alerta
para seguir os movimentos de executivos da Rome Therapeutics.
Biotecnologia
Rome Therapeutics possui 2.406 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).
Popular M&A news in Biotecnologia
- Oak Hill Bio acaba de anunciar uma arrecadação de fundos de 33 milhões de dólares. (publicado em 4 de junho de 2026).
- IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
- NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Rome Therapeutics
- ROME Therapeutics Announces Publication in Nature Communications of First Large-Scale, Pan-Cancer Analysis of LINE-1 Expression Levels and Retrotransposon Activity – ROME Therapeutics
- ROME Therapeutics Debuts First Preclinical Data of its LINE-1 Reverse Transcriptase (RT) Inhibitors in Neurodegenerative Diseases at 3rd Annual Dark Genome Symposium – ROME Therapeutics
- ROME Therapeutics to Present Data Supporting LINE-1 Reverse Transcriptase Inhibitors as a Novel Treatment for Autoimmune Diseases at ACR Convergence 2024 – ROME Therapeutics
- ROME Therapeutics, Enara Bio, Nucleome Therapeutics and NYU Langone Health to Host 3rd Annual Dark Genome Symposium – ROME Therapeutics
- ROME Therapeutics to Participate in 2024 Cantor Global Healthcare Conference – ROME Therapeutics
- ROME Therapeutics to Participate in 2024 Wedbush PacGrow Healthcare Conference – ROME Therapeutics
- ROME Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference – ROME Therapeutics
- ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer – ROME Therapeutics
- ROME Publishes Landmark Nature Paper Revealing First High-Resolution Structure of LINE-1 Reverse Transcriptase (RT) for Drug Discovery – ROME Therapeutics
- ROME Therapeutics Presents First Data to Validate LINE-1 RT as a Novel Target in Autoimmune Diseases and the Therapeutic Potential of its First-in-Class LINE-1 RT Inhibitors – ROME Therapeutics
- View more press releases Close
Redes sociais sobre Rome Therapeutics
- Rome Therapeutics na Wikipedia, Google News e Yahoo Finance
- Rome Therapeutics na LinkedIn, X (Twitter) e YouTube
